chr15-52205052-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018728.4(MYO5C):c.4633G>A(p.Gly1545Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000688 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018728.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYO5C | NM_018728.4 | c.4633G>A | p.Gly1545Ser | missense_variant | 38/41 | ENST00000261839.12 | |
CERNA1 | NR_102751.1 | n.693C>T | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYO5C | ENST00000261839.12 | c.4633G>A | p.Gly1545Ser | missense_variant | 38/41 | 1 | NM_018728.4 | P1 | |
CERNA1 | ENST00000654724.1 | n.691C>T | non_coding_transcript_exon_variant | 3/3 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000168 AC: 42AN: 249428Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135350
GnomAD4 exome AF: 0.0000445 AC: 65AN: 1461874Hom.: 0 Cov.: 31 AF XY: 0.0000440 AC XY: 32AN XY: 727242
GnomAD4 genome AF: 0.000302 AC: 46AN: 152256Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.4633G>A (p.G1545S) alteration is located in exon 38 (coding exon 38) of the MYO5C gene. This alteration results from a G to A substitution at nucleotide position 4633, causing the glycine (G) at amino acid position 1545 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at